(Q39972485)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Manon Buijs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jean-Francois H Geschwind

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Takayoshi Ishimori

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

James M Engles

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Obele Acha-Ngwodo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Richard L Wahl

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mustafa Vali

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

1 reference

14 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

120-123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18553054%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10637-008-9145-0

9 January 2020

exact match

0 references

cites work

Surgery for liver metastases from breast cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-008-9145-0

Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-008-9145-0

Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-008-9145-0

Oncological applications of FDG PET imaging

21 January 2018

1 reference

12 December 2020

Importance of extended growth potential and growth factor independence on in vivo neoplastic potential of primary rat mammary carcinoma cells

1 reference

12 December 2020

Determination of 2-fluoro-2-deoxy-D-glucose uptake and ATP level for evaluating drug effects in neoplastic cells.

1 reference

12 December 2020

PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients

1 reference

12 December 2020

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

1 reference

12 December 2020

Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis

1 reference

12 December 2020

Current management of metastatic breast cancer

1 reference

12 December 2020

Evaluating distant metastases in breast cancer: from biology to outcomes.

1 reference

12 December 2020

Understanding breast cancer risk -- where do we stand in 2005?

1 reference

12 December 2020

Impact of chemotherapy in women with metastatic breast cancer diagnosed 1990-2003.

1 reference

12 December 2020

Molecular imaging techniques in body imaging

1 reference

12 December 2020

Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase

1 reference

12 December 2020

Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy.

1 reference

12 December 2020

Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.

1 reference

12 December 2020

Intraarterial Therapy with a New Potent Inhibitor of Tumor Metabolism (3-bromopyruvate): Identification of Therapeutic Dose and Method of Injection in an Animal Model of Liver Cancer

1 reference

12 December 2020

Hepatic Intra-arterial Injection of 3-Bromopyruvate in Rabbit VX2 Tumor

1 reference

12 December 2020

Initial experience with FDG-PET/CT in the evaluation of breast cancer

1 reference

12 December 2020

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

1 reference

12 December 2020

Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Uncommon breast tumors in perspective: Incidence, treatment and survival in the Netherlands

1 reference

12 December 2020

Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma.

1 reference

12 December 2020

Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma

1 reference

12 December 2020